LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

ALX Oncology Holdings Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERALXO
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ALXO COVERAGE

What’s moving ALX Oncology Holdings Inc. now

Current reporting with the operating signal separated from the noise.

01
GuruFocus

BlackRock, Inc. Expands Stake in ALX Oncology Holdings Inc (ALXO) with Strategic Share Purchase

Investors are testing whether ALX Oncology Holdings Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
TradingKey

ALX Oncology Holdings Inc (ALXO) Risk Assessment: Volatility, Financial Risk & Investment Risk

The story matters when it changes ALX Oncology Holdings Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
TradingKey

ALX Oncology Holdings Inc (ALXO) Financial Health: Profitability & Balance Sheet Analysis

Investors are testing whether ALX Oncology Holdings Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
TradingKey

ALX Oncology Holdings Inc (ALXO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Investors are testing whether ALX Oncology Holdings Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
TradingKey

ALX Oncology Holdings Inc (ALXO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

The story matters when it changes ALX Oncology Holdings Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ALXO filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-08 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-07 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-09 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-30 · Period 2026-06-29SEC ↗8-KMaterial company eventFiled 2026-06-26 · Period 2026-06-25SEC ↗8-KMaterial company eventFiled 2026-06-11 · Period 2026-06-10SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-20 · Period 2026-04-17SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-27SEC ↗
EARNINGS / QUARTERLY TRACKER

ALX Oncology Holdings Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.